» Authors » Aline S C Fabricio

Aline S C Fabricio

Explore the profile of Aline S C Fabricio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 502
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Trevisiol C, Cani I, Fabricio A, Gion M, Giometto B, De Massis P
Front Neurol . 2021 Feb; 11:607553. PMID: 33536995
Algorithms for the detection of a malignancy in patients with unclear neurologic symptoms of suspicious paraneoplastic origins are not universally applied. Frequently, circulating tumor markers (TMs) are considered a valuable...
12.
Trevisiol C, Gion M, Vaona A, Fabricio A, Roca E, Licitra L, et al.
Oral Oncol . 2021 Jan; 114:105128. PMID: 33444925
Background: In EBV-related nasopharyngeal carcinoma (NPC), quantitative determination of circulating EBV-DNA (cEBV-DNA) can potentially be applied as disease marker. The aim of the study was to investigate if the clinical...
13.
Dalla Zuanna T, Savitz D, Barbieri G, Pitter G, Zare Jeddi M, Dapra F, et al.
Ecotoxicol Environ Saf . 2020 Dec; 209:111805. PMID: 33360787
Background: Residents of a large area of North-Eastern Italy were exposed for decades to high concentrations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) via drinking water. Serum PFAS levels have been...
14.
Pitter G, Zare Jeddi M, Barbieri G, Gion M, Fabricio A, Dapra F, et al.
Environ Health . 2020 Sep; 19(1):102. PMID: 32958007
Background: Residents in a large area of North-Eastern Italy were exposed to perfluoroalkyl substances (PFAS) via drinking water. Studies on the association between PFAS and blood pressure levels are limited,...
15.
Elhasnaoui J, Miano V, Ferrero G, Doria E, Leon A, Fabricio A, et al.
Cancers (Basel) . 2020 Jun; 12(6). PMID: 32503257
is a cancer-related long noncoding RNA with higher expression levels in Luminal A, B, and HER2-positive Breast Carcinoma (BC), where its expression is strongly dependent on Estrogen Receptor Alpha (ERα)....
16.
Agnolon V, Contato A, Meneghello A, Tagliabue E, Toffoli G, Gion M, et al.
Sci Rep . 2020 Feb; 10(1):3016. PMID: 32080226
Circulating HER2 extracellular domain (HER2 ECD) levels were proposed as a surrogate for HER2 tissue expression to monitor breast cancer patients for early relapse or responses to standard or HER2-targeted...
17.
Gion M, Trevisiol C, Fabricio A
Int J Biol Markers . 2020 Feb; 35(1_suppl):12-15. PMID: 32079467
The role of biomarkers is crucial in oncology for both early diagnosis and the personalization of cancer treatments. Tissue biomarkers have gained a central role as predictors of the response...
18.
Trevisiol C, Cinquini M, Fabricio A, Gion M, Rutjes A
BMC Med Res Methodol . 2019 Aug; 19(1):180. PMID: 31429714
Background: The use of systematic review methods are widely recognized to be essential in the development of recommendations in clinical practice guidelines to prove their trustworthiness. The objective of this...
19.
Fabricio A, Michilin S, Zancan M, Agnolon V, Peloso L, Dittadi R, et al.
Scand J Clin Lab Invest . 2019 Apr; 79(4):260-267. PMID: 30982358
The aim of the present study was to investigate serum HER2 extracellular domain (ECD) as a putative surrogate marker of the shedding phenomenon of HER2 receptor from the tumor tissue...
20.
Dittadi R, Fabricio A, Rainato G, Peroni E, Di Tonno F, Vezzu B, et al.
Clin Chem Lab Med . 2018 Sep; 57(4):521-531. PMID: 30218601
Background [-2]proPSA seems to outperform free/total prostate-specific antigen (PSA) ratio in prostate cancer diagnosis. However, [-2]proPSA stability remains an underestimated issue. We examined [-2]proPSA stability over time in whole blood...